Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Different diseases cause specific skin and hair follicle changes in dogs with alopecia.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Immunofluorescence tomography is a cost-effective method for creating detailed 3-D images of tissues.

ILC1 cells contribute to hair loss in alopecia areata.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Nonsegmental vitiligo is caused by the immune system attacking skin cells, often linked to other autoimmune diseases.

Immune cells might contribute to hair loss caused by a specific mutation.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.